Study on defibrinogenasing enhancing the thrombolytic effect of urokinase on acute myocardial infarction

OBJECTIVE: To investigate the thrombolytic effects and the security of combined therapy of defibrinogenase (DEF) and lower dose urokinase (UK) on patients with acute myocardial infarction (AMI)

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 15(2003), 8 vom: 15. Aug., Seite 462-4
1. Verfasser: Wu, Xu-hui (VerfasserIn)
Weitere Verfasser: Hong, Shao-cai, Liu, Ying-ming, Li, Tan-shi, Xiang, Ding-cheng, Lu, Guang-sen
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2003
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:Clinical Trial English Abstract Journal Article Research Support, Non-U.S. Gov't Fibrinolytic Agents Urokinase-Type Plasminogen Activator EC 3.4.21.73